MSK experts discuss FLAURA2 updates, emerging targets in mesothelioma, and next-gen immunotherapies from the 2026 European Lung Cancer Congress.
Michael Offin, MD
Michael Offin, MD, is a thoracic medical oncologist and co-director of the Mesothelioma Program at Memorial Sloan Kettering Cancer Center.
Articles by Michael Offin, MD